EUVIMEDEUVIMED entdecken
Crossref

Position Statement and Consensus Recommendation of the Immunonephrology Working Group of the Portuguese Society of Nephrology on the Management of Proliferative Lupus Nephritis and the Use of Old and Emergent Combination Therapies

Estela Nogueira, Inês Castro Ferreira, Iolanda Godinho, Sofia Correia, Alice Lança, Raquel Vaz, Helena Pinto, Ivo Laranjinha, Teresa M. Jerónimo, Clara Santos, António da Silva Inácio, Nuno A Oliveira

Portuguese Kidney Journal (PKJ) · 28.02.2026

DOI: 10.71749/pkj.139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Portuguese Kidney Journal (PKJ), erschienen am 28.02.2026. Verfasst von Estela Nogueira und 11 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis is an immune complex mediated glomerulonephritis representing one of the most severe manifestations of systemic lupus erythematosus. Despite advances in therapy, progression to chronic kidney disease remains significantly high, underlining the need for more effective drug regimens that encompass less long-term toxicity. Recently, lupus nephritis has been reframed as a form of chronic kidney disease, shifting therapeutic goals toward three main pillars: sustained immunological control with prevention of relapse, interventions that target non-immune factors of chronic kidney disease and strategies that minimize infection risk. The emergence of novel therapeutic agents has prompted updates of major international guidelines, with new combination drug schemes that increase efficacy and allow glucocorticoid sparing. This position statement reviews the KDIGO 2024, ACR 2024, and EULAR 2025 recommendations and presents the Immunophenology Working Group of the Portuguese Society of Nephrology perspective on the management of proliferative Lupus nephritis - Classes III and IV, according to our national context.

Schlagwörter

proliferative lupus nephritislupus nephritissystemic lupus erythematosuscombination therapysteroid-sparing therapychronic kidney diseaseimmune controlinfection riskrelapse preventionnovel therapeutic agents

Zitieren

APA

Nogueira, E., Ferreira, I. C., Godinho, I., Correia, S., Lança, A., Vaz, R., Pinto, H., Laranjinha, I., Jerónimo, T. M., Santos, C., Inácio, A. D. S., & Oliveira, N. A. (2026). Position Statement and Consensus Recommendation of the Immunonephrology Working Group of the Portuguese Society of Nephrology on the Management of Proliferative Lupus Nephritis and the Use of Old and Emergent Combination Therapies. Portuguese Kidney Journal (PKJ). https://doi.org/10.71749/pkj.139

Vancouver

Nogueira E, Ferreira IC, Godinho I, Correia S, Lança A, Vaz R, et al. Position Statement and Consensus Recommendation of the Immunonephrology Working Group of the Portuguese Society of Nephrology on the Management of Proliferative Lupus Nephritis and the Use of Old and Emergent Combination Therapies. Portuguese Kidney Journal (PKJ). 2026. doi:10.71749/pkj.139

BibTeX
@article{Nogueira2026,
  author = {Nogueira, Estela and Ferreira, Inês Castro and Godinho, Iolanda and Correia, Sofia and Lança, Alice and Vaz, Raquel and Pinto, Helena and Laranjinha, Ivo and Jerónimo, Teresa M. and Santos, Clara and Inácio, António da Silva and Oliveira, Nuno A},
  title = {Position Statement and Consensus Recommendation of the Immunonephrology Working Group of the Portuguese Society of Nephrology on the Management of Proliferative Lupus Nephritis and the Use of Old and Emergent Combination Therapies},
  journal = {Portuguese Kidney Journal (PKJ)},
  year = {2026},
  doi = {10.71749/pkj.139}
}
Kostenlos starten →